bpc 157 and dap Banned: Key Facts on the Latest FDA Decision Stable Gastric Pentadecapeptide BPC 157
Description
Not for Diagnostic or Therapeutic Applications
Signals were quantified using Image Lab (Bio-Rad)
HASSALL, C.D., GANDOLFI A.J., & BRENDEL K
Enhanced fecal bile acid excretion creates a greater demand for cholesterol conversion to bile acids, further reducing circulating cholesterol levels
Category 2 peptides: banned from compounding Category 2 is where most popular research peptides end up
